Wadsworth, IL, United States of America

Jeremy C Packer

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignees: Abbvie Inc., Myriad Genetics, Inc.. Active years: 2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jeremy C Packer. Retrieved from https://idiyas.com/inventor/jeremy-c-packer

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2015

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Inventor Profile: Jeremy C. Packer

Introduction

Jeremy C. Packer, an innovative inventor hailing from Wadsworth, Illinois, has made significant contributions to the field of biotechnology. With a focus on understanding and treating major depressive disorder and related conditions, Packer has developed groundbreaking research that has potential therapeutic applications.

Latest Patents

Jeremy Packer holds a patent for DEP2, a protein with applications in the treatment of major depression and its related disorders. This invention represents a significant advancement in the ongoing search for effective interventions in psychiatric health.

Career Highlights

Throughout his career, Jeremy has worked with prominent companies in the pharmaceutical and genetics sectors. Notably, he has contributed his expertise at AbbVie Inc. and Myriad Genetics, Inc. These experiences have provided him with a robust foundation in both research and application of his inventions.

Collaborations

Jeremy's work has seen him collaborate with esteemed colleagues, including David A. Katz and Anahita Bhathena. These partnerships have been instrumental in furthering his research and expanding the reach and impact of his patent.

Conclusion

In summary, Jeremy C. Packer is an accomplished inventor dedicated to advancing the understanding and treatment of mental health disorders. His work on DEP2 illustrates his commitment to innovation and the potential for significant advancements in therapeutic approaches to major depressive disorder.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…